Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LF.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.7.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.7.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.18.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.18.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.16.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.16.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.16.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.16.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LR.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LR.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KR.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KR.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-2013.34China
KR.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JD.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used